The biosurgical agent market in Europe is primarily driven by growing surgical procedure volumes, rising awareness of the benefits of these products in surgical outcomes, and the introduction of new products with enhanced features and expanded indications. However, the European market continues to be limited by a lack of reimbursement for biosurgical agents, growing concerns over product cost and reluctance to use products derived from human tissue among some physicians and patients, hindering the pace of market growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biosurgical agents in Europe, with market projections across a 10-year period.

Increasing surgical procedure volumes in Europe will largely dictate the growth of the overall market.

Which surgical specialties have the largest market size for biosurgical agents?

How will declining procedure volumes in certain surgical specialties affect market growth?

Product penetration by surgical specialty will influence overall market trends.

Which specialty type has seen the highest overall penetration of biosurgical agents?

Which biosurgical agent materials are most popular and drive unit sales within each specialty?

Despite cost-containment efforts across European health care systems, biosurgical agent ASPs will not decline significantly.

How will ASP trends differ by product type and across countries?

What pricing strategies are companies employing?

Product innovation and the expansion of approved indications will support market growth.

What new products are anticipated to enter the market and how will they be received?

How will new indications impact market growth and surgeon adoption?

Which companies have obtained expanded approvals for new indications?

The COVID-19 outbreak will have an impact on the biosurgical agent market in Europe.

How will COVID-19 affect the sales and revenues of biosurgical agents in Europe?

Which procedure types will be most strongly impacted by challenges associated with COVID-19

Table of contents

  • Biosurgical Agents - Market Insights - Europe

Author(s): Muskan Kishore, MBA(Pharm)

Muskan Kishore is a market expert specializing in gastrointestinal endoscopy devices within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group. Muskan Kishore holds a Bachelor's degree in Pharmacy from Panjab University, Chandigarh, and an MBA (Pharm) from the National Institute Of Pharmaceutical Sciences And Research (Mohali), Punjab.


Related Reports

Biosurgical Agents - Market Insights - Europe (Supplemental)

The biosurgical agent market in Europe is primarily driven by growing surgical procedure volumes, rising awareness of the benefits of these...

View Details

Biosurgical Agents - Market Insights - Asia Pacific (Supplemental)

The Asia Pacific biosurgical agents market is primarily driven by growing surgical procedure volumes due to expanding aging population and the rising prevalence of diseases associated w...

View Details

Biosurgical Agents - Market Insights - Asia Pacific

The Asia Pacific biosurgical agents market is primarily driven by growing surgical procedure volumes due to expanding aging population and the rising prevalence of diseases associated w...

View Details

Biosurgical Agents - Market Insights - Japan

The biosurgical agent market in Japan will grow moderately, driven by rising surgical procedure volumes, the introduction of new products, and expanding indications for the existing products.&nbs...

View Details